Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Clinical trial NCT04222413 · RECRUITING

Trial details

NCT number: NCT04222413
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Metastatic Pancreatic Cancer Pediatric Solid Tumor Advanced Breast Cancer Malignant Peripheral Nerve Sheath Tumor Colorectal Neoplasms

Start date: 2020-10-27
Primary completion: 2027-12-31
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.